Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Interferon alpha-2b gene therapy - Cerecor

Next Previous
X
Search
Drug Profile

Interferon alpha-2b gene therapy - Cerecor

Alternative Names: Infradure; Infradure Biopump

Latest Information Update: 30 Dec 2016

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Medgenics
  • Class Antivirals; Cytokine genes; IFNA2B gene therapies; Interferons
  • Mechanism of Action Gene transference; IFNA2B expression stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Hepatitis D
  • New Molecular Entity No
  • Available For Licensing Yes - Hepatitis B; Hepatitis C; Hepatitis D

Highest Development Phases

  • Discontinued Hepatitis B; Hepatitis C; Hepatitis D

Most Recent Events

  • 15 Dec 2016 Medgenics is now called Aevi Genomic Medicine
  • 16 Apr 2014 Medgenics withdraws phaseI/II trial in Hepatitis C (recurrent) in Israel prior to enrolment (NCT01430000)
  • 01 Mar 2014 Medgenics terminates phase I/II trial in Hepatitis C in Israel (NCT01433133)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top